HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minoru Shiraga Selected Research

N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamide

3/2003A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice.
10/2002Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minoru Shiraga Research Topics

Disease

2Neoplasm Metastasis (Metastasis)
03/2003 - 10/2002
2Neoplasms (Cancer)
03/2003 - 10/2002
1Neoplasm Micrometastasis
03/2003
1Body Weight (Weight, Body)
03/2003
1Inflammation (Inflammations)
02/2003
1Asthma (Bronchial Asthma)
02/2003
1Lung Neoplasms (Lung Cancer)
10/2002

Drug/Important Bio-Agent (IBA)

2N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamideIBA
03/2003 - 10/2002
2Matrix Metalloproteinases (MMPs)IBA
03/2003 - 10/2002
2Matrix Metalloproteinase InhibitorsIBA
03/2003 - 10/2002
1Pharmaceutical PreparationsIBA
03/2003
1Docetaxel (Taxotere)FDA Link
03/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2003
1SteroidsIBA
02/2003

Therapy/Procedure

2Therapeutics
03/2003 - 02/2003